[1] Fox C S, Muntner P, Chen A Y, et al. Use of evidence-based therapies in short-term outcomes of ST-segment elevation myocardial infarction and non-ST-segment elevation myocardial infarction in patients with chronic kidney disease: a report from the National Cardiovascular Data Acute Coronary Treatment and Intervention Outcomes Network registry [J]. Circulation,2010,121(3):357-365.
[2] Wong J A, Goodman S G, Yan R T, et al. Temporal management patterns and outcomes of non-ST elevation acute coronary syndromes in patients with kidney dysfunction [J]. Eur Heart J,2009,30(5):549-557.
[3] Masoudi F A, Plomondon M E, Magid D J, et al. Renal insufficiency and mortality from acute coronary syndromes [J]. Am Heart J,2004,147(4):623-629.
[4] Best P J, Lennon R, Ting H H, et al. The impact of renal insufficiency on clinical outcomes in patients undergoing percutaneous coronary interventions [J]. J Am Coll Cardiol,2002,39(7):1113-1119.
[5] Baber U, Stone G W, Weisz G, et al. Coronary plaque composition, morphology, and outcomes in patients with and without chronic kidney disease presenting with acute coronary syndromes [J]. JACC Cardiovasc Imaging,2012,5(3 Suppl):S53-S61.
[6] Pelisek J, Hahntow I N, Eckstein H H, et al. Impact of chronic kidney disease on carotid plaque vulnerability [J]. J Vasc Surg,2011,54(6):1643-1649.
[7] Lu B, Dai R, Bai H, et al. Detection and analysis of intracoronary artery stent after PTCA using contrast-enhanced three-dimensional electron beam tomography [J]. J Invasive Cardiol,2000,12(1):1-6.